ciprofloxacin has been researched along with Infection, Wound in 68 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " aeruginosa isolated from cystic fibrosis and wound patients, and one laboratory strain was treated singly and with combinations of anti-Pseudomonas phage PEV20 and ciprofloxacin." | 7.91 | Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. ( Chan, HK; Chang, RYK; Das, T; Kutter, E; Manos, J; Morales, S, 2019) |
| " This research focuses on the feasibility of using silver- and fluoride-containing BGs against multidrug-resistant bacterial strains isolated from patients with burns." | 7.83 | Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. ( Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F, 2016) |
| " aeruginosa isolated from cystic fibrosis and wound patients, and one laboratory strain was treated singly and with combinations of anti-Pseudomonas phage PEV20 and ciprofloxacin." | 3.91 | Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. ( Chan, HK; Chang, RYK; Das, T; Kutter, E; Manos, J; Morales, S, 2019) |
| " This research focuses on the feasibility of using silver- and fluoride-containing BGs against multidrug-resistant bacterial strains isolated from patients with burns." | 3.83 | Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. ( Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F, 2016) |
| "Food and Drug Administration regulations state that ciprofloxacin hydrochloride may cause arthropathies." | 3.70 | Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated? ( Desai, M; Edgar, P; Heggers, JP; Herndon, DN; John, SD; Klein, GL; Villarreal, C; Wolf, S, 1998) |
| "Ciprofloxacin may be considered as first-line treatment for a number of infections in which gram-negative pathogens are proven or strongly suspected, including complicated urinary tract infections, bacterial prostatitis, bacterial diarrhea, selected bone and joint infections, malignant otitis externa, bronchopulmonary infections in patients with cystic fibrosis and selected pneumonia cases." | 3.69 | Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. ( Louie, TJ, 1994) |
| " Furthermore, reducing the dosage of antibiotics can lead to an improvement in the toxic effects caused by dose-dependent antibiotics and antimicrobial activity." | 1.91 | Evaluation of combined carbon dots and ciprofloxacin on the expression level of pslA, pelA, and ppyR genes and biofilm production in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from burn wound infection in Iran. ( Abiri, R; Alvandi, AH; Barati, A; Delnavazi, MR; Karimiravesh, R; Mobarez, AM; Nikkhah, M; Pajavand, H, 2023) |
| "Wound infections are associated with morbidity and mortality in developing countries." | 1.72 | Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Risk Factors Among Patients With Wound Infections at Debre Markos Referral Hospital, Northwest, Ethiopia. ( Shimekaw, M; Tessema, B; Tigabu, A, 2022) |
| "In a mouse skin wound infection model, F6 was equipotent to the antibiotic fusidic acid in reducing MRSA burden." | 1.48 | N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria. ( Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO, 2018) |
| "aeruginosa murine burn wound infection." | 1.42 | Efficacy of purified lactonase and ciprofloxacin in preventing systemic spread of Pseudomonas aeruginosa in murine burn wound model. ( Chhibber, S; Gupta, P; Harjai, K, 2015) |
| "To achieve this, a burn wound infection model was established in mice by using a highly pathogenic burn wound clinical isolate of P." | 1.32 | Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa. ( Dale, RM; Schnell, G; Wong, JP, 2004) |
| "Healing of poorly vascularized and venous stasis ulcers is often refractory to therapy, particularly when they are infected." | 1.31 | A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. ( Katsarava, R; Markoishvili, K; Morris, JG; Sulakvelidze, A; Tsitlanadze, G, 2002) |
| "Wounds with necrotising fasciitis are often malodorous and produce copious exudate." | 1.31 | Management of a heavily exuding, painful wound with necrotising subcutaneous infection. ( Fairhurst, J; Ovens, N, 2002) |
| "Levofloxacin was generally one to two dilutions more active than ofloxacin, while ciprofloxacin was active against aerobes (MIC < or = 1 mg/L) but less active against anaerobic strains (MIC90 < or = 16 mg/L)." | 1.30 | Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens. ( Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV, 1998) |
| "Vancomycin was the most effective prophylactic agent, exhibiting in vivo activity against all strains which was superior or equivalent to those of all other agents tested." | 1.29 | Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection. ( Kaiser, AB; Kernodle, DS, 1994) |
| "Cefuroxime was generally greater than fourfold more active than cephalexin and cefadroxil against all aerobic isolates, including Pasteurella multocida." | 1.27 | Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds. ( Citron, DM; Goldstein, EJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (7.35) | 18.7374 |
| 1990's | 15 (22.06) | 18.2507 |
| 2000's | 19 (27.94) | 29.6817 |
| 2010's | 19 (27.94) | 24.3611 |
| 2020's | 10 (14.71) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, S | 1 |
| Nakai, T | 1 |
| Wakai, Y | 1 |
| Ikeda, F | 1 |
| Hatano, K | 1 |
| Opoku-Temeng, C | 1 |
| Naclerio, GA | 1 |
| Mohammad, H | 1 |
| Dayal, N | 1 |
| Abutaleb, NS | 1 |
| Seleem, MN | 1 |
| Sintim, HO | 1 |
| Kumar, S | 1 |
| Pal, S | 1 |
| Thakur, J | 1 |
| Rani, P | 1 |
| Rana, K | 1 |
| Kar, A | 1 |
| Kar, R | 1 |
| Mehta, D | 1 |
| Jha, SK | 1 |
| Pradhan, MK | 1 |
| Jain, D | 1 |
| Rajput, K | 1 |
| Mishra, S | 1 |
| Ganguli, M | 1 |
| Srivastava, A | 1 |
| Dasgupta, U | 1 |
| Patil, VS | 1 |
| Bajaj, A | 1 |
| Laulund, AS | 2 |
| Schwartz, FA | 1 |
| Christophersen, L | 3 |
| Høiby, N | 3 |
| Svendsen, JSM | 1 |
| Stensen, W | 1 |
| Thomsen, K | 3 |
| Cavanagh, JP | 1 |
| Moser, C | 3 |
| Calum, H | 2 |
| Trøstrup, H | 2 |
| Amiri, P | 1 |
| Kardan-Yamchi, J | 1 |
| Kazemian, H | 1 |
| Rezaei, F | 1 |
| Liu, Q | 1 |
| Zhang, Y | 1 |
| Huang, J | 1 |
| Xu, Z | 1 |
| Li, X | 1 |
| Yang, J | 1 |
| Huang, H | 1 |
| Tang, S | 1 |
| Chai, Y | 1 |
| Lin, J | 1 |
| Yang, C | 1 |
| Liu, J | 1 |
| Lin, S | 1 |
| Shafigh Kheljan, F | 1 |
| Sheikhzadeh Hesari, F | 1 |
| Aminifazl, MS | 1 |
| Skurnik, M | 1 |
| Gholadze, S | 1 |
| Zarrini, G | 1 |
| Pajavand, H | 1 |
| Mobarez, AM | 1 |
| Barati, A | 1 |
| Nikkhah, M | 1 |
| Delnavazi, MR | 1 |
| Abiri, R | 1 |
| Alvandi, AH | 1 |
| Karimiravesh, R | 1 |
| Weldrick, PJ | 1 |
| Hardman, MJ | 1 |
| Paunov, VN | 1 |
| Mazumder, R | 1 |
| Sadique, T | 1 |
| Sen, D | 1 |
| Mozumder, P | 1 |
| Rahman, T | 1 |
| Chowdhury, A | 1 |
| Halim, F | 1 |
| Akter, N | 1 |
| Ahmed, D | 1 |
| Shimekaw, M | 1 |
| Tigabu, A | 1 |
| Tessema, B | 1 |
| Majere, RA | 1 |
| Cortina, S | 1 |
| Chang, RYK | 1 |
| Das, T | 1 |
| Manos, J | 1 |
| Kutter, E | 1 |
| Morales, S | 1 |
| Chan, HK | 1 |
| Laulund, ASB | 1 |
| Lerche, CJ | 1 |
| Carro, GV | 1 |
| Carlucci, E | 1 |
| Priore, G | 1 |
| Gette, F | 1 |
| Llanos, MLA | 1 |
| Dicatarina Losada, MV | 1 |
| Noli, ML | 1 |
| Amato, PS | 1 |
| Nichols, DP | 1 |
| Caceres, S | 1 |
| Caverly, L | 1 |
| Fratelli, C | 1 |
| Kim, SH | 1 |
| Malcolm, K | 1 |
| Poch, KR | 1 |
| Saavedra, M | 1 |
| Solomon, G | 1 |
| Taylor-Cousar, J | 1 |
| Moskowitz, S | 1 |
| Nick, JA | 1 |
| Pence, MA | 1 |
| Sharon, J | 1 |
| McElvania Tekippe, E | 1 |
| Pakalniskis, BL | 1 |
| Ford, BA | 1 |
| Burnham, CA | 1 |
| Islam, S | 1 |
| Cawich, SO | 1 |
| Budhooram, S | 1 |
| Harnarayan, P | 1 |
| Mahabir, V | 1 |
| Ramsewak, S | 1 |
| Naraynsingh, V | 1 |
| Carrington, S | 1 |
| Cohall, DH | 1 |
| Gossell-Williams, M | 1 |
| Lindo, JF | 1 |
| Halenka, M | 1 |
| Bergmann, PA | 1 |
| Mauss, KL | 1 |
| Liodaki, ME | 1 |
| Mailänder, P | 1 |
| Siemers, F | 1 |
| Stang, F | 1 |
| Gupta, P | 1 |
| Chhibber, S | 1 |
| Harjai, K | 1 |
| Cano García, ME | 1 |
| Monteagudo Cimiano, I | 1 |
| Mellado Encinas, P | 1 |
| Ortega Álvarez, C | 1 |
| Gholipourmalekabadi, M | 1 |
| Sameni, M | 1 |
| Hashemi, A | 1 |
| Zamani, F | 1 |
| Rostami, A | 1 |
| Mozafari, M | 1 |
| Roy, DC | 1 |
| Tomblyn, S | 1 |
| Isaac, KM | 1 |
| Kowalczewski, CJ | 1 |
| Burmeister, DM | 1 |
| Burnett, LR | 1 |
| Christy, RJ | 1 |
| Dambrauskiene, A | 1 |
| Adukauskiene, D | 1 |
| Jeroch, J | 1 |
| Vitkauskiene, A | 1 |
| Preda, TC | 1 |
| Preda, VA | 1 |
| Mekisic, AP | 1 |
| Hill, KE | 1 |
| Malic, S | 1 |
| McKee, R | 1 |
| Rennison, T | 1 |
| Harding, KG | 1 |
| Williams, DW | 1 |
| Thomas, DW | 1 |
| Kostenko, V | 1 |
| Lyczak, J | 1 |
| Turner, K | 1 |
| Martinuzzi, RJ | 1 |
| Giráldez, P | 1 |
| Mayo, E | 1 |
| Pavón, P | 1 |
| Losada, A | 1 |
| Su, LH | 1 |
| Wu, TL | 1 |
| Chiu, CH | 1 |
| Markoishvili, K | 1 |
| Tsitlanadze, G | 1 |
| Katsarava, R | 1 |
| Morris, JG | 1 |
| Sulakvelidze, A | 1 |
| Sripriya, R | 1 |
| Kumar, MS | 1 |
| Sehgal, PK | 1 |
| Dale, RM | 1 |
| Schnell, G | 1 |
| Wong, JP | 1 |
| Dubouix, A | 1 |
| Bonnet, E | 1 |
| Alvarez, M | 1 |
| Bensafi, H | 1 |
| Archambaud, M | 1 |
| Chaminade, B | 1 |
| Chabanon, G | 1 |
| Marty, N | 1 |
| Tsou, TL | 1 |
| Tang, ST | 1 |
| Huang, YC | 1 |
| Wu, JR | 1 |
| Young, JJ | 1 |
| Wang, HJ | 1 |
| Draenert, R | 1 |
| Kunzelmann, M | 1 |
| Roggenkamp, A | 1 |
| Hellers, J | 1 |
| Bogner, JR | 1 |
| Teneza-Mora, N | 1 |
| Dull, M | 1 |
| Crum-Cianflone, N | 1 |
| Pérez de Pedro, I | 1 |
| de la Quintana-Beltrán, P | 1 |
| Bermúdez-Ruiz, P | 1 |
| Negroni, R | 1 |
| Bianchi, MH | 1 |
| Arechavala, AI | 1 |
| Maiolo, E | 1 |
| Santiso, G | 1 |
| Olivares, L | 1 |
| Cooke, FJ | 1 |
| Howard, JC | 1 |
| Hugh-Jones, C | 1 |
| Brown, NM | 1 |
| Khorasani, G | 1 |
| Salehifar, E | 1 |
| Eslami, G | 1 |
| Raz, R | 1 |
| Miron, D | 1 |
| Kernodle, DS | 1 |
| Kaiser, AB | 1 |
| Newton, JA | 1 |
| Kennedy, CA | 1 |
| Louie, TJ | 1 |
| Kemmerly, SA | 1 |
| Pankey, GA | 2 |
| Knapp, TP | 1 |
| Patzakis, MJ | 2 |
| Lee, J | 2 |
| Seipel, PR | 1 |
| Abdollahi, K | 1 |
| Reisch, RB | 1 |
| Goldstein, EJ | 3 |
| Citron, DM | 3 |
| Hunt Gerardo, S | 2 |
| Hudspeth, M | 2 |
| Merriam, CV | 2 |
| Ebrey, RJ | 1 |
| Hayek, LJ | 1 |
| Heggers, JP | 1 |
| Villarreal, C | 1 |
| Edgar, P | 1 |
| Wolf, S | 1 |
| Klein, GL | 1 |
| John, SD | 1 |
| Desai, M | 1 |
| Herndon, DN | 1 |
| Krutikov, MG | 1 |
| Wilcox, RA | 1 |
| Chin, GK | 1 |
| Segasothy, M | 1 |
| Bains, RS | 1 |
| Shepherd, L | 1 |
| Singer, G | 1 |
| Ressler, R | 1 |
| Harvey, F | 1 |
| Holtom, P | 1 |
| Ovens, N | 1 |
| Fairhurst, J | 1 |
| Estahbanati, HK | 1 |
| Kashani, PP | 1 |
| Ghanaatpisheh, F | 1 |
| Iakovlev, VP | 1 |
| Collins, MS | 3 |
| Ladehoff, D | 1 |
| Mehton, NS | 1 |
| Dugoni-Kramer, BM | 1 |
| Wang, DW | 1 |
| Meadors, MC | 1 |
| Gentry, LO | 1 |
| Ramirez-Ronda, CH | 1 |
| Rodriguez-Noriega, E | 1 |
| Thadepalli, H | 1 |
| del Rosal, PL | 1 |
| Ramirez, C | 1 |
| Scully, BE | 1 |
| Neu, HC | 1 |
| Parry, MF | 1 |
| Mandell, W | 1 |
| Hector, RF | 2 |
| Roby, RE | 2 |
| Edwards, AA | 1 |
| Ladehoff, DK | 1 |
| Dorsey, JH | 2 |
| Tsay, GC | 1 |
5 reviews available for ciprofloxacin and Infection, Wound
| Article | Year |
|---|---|
Murine burn lesion model for studying acute and chronic wound infections.
Topics: Animals; Biofilms; Burns; Calgranulin A; Ciprofloxacin; Disease Models, Animal; Humans; Mice; Pseudo | 2022 |
Non-surgical management of thyroid abscess with ultrasound-guided fine-needle application of an antibiotic followed by sclerotization with absolute alcohol.
Topics: Abscess; Adult; Anti-Bacterial Agents; Biopsy, Fine-Needle; Ciprofloxacin; Combined Modality Therapy | 2013 |
[Skin infection due to Serratia marcescens in an immunocompetent patient].
Topics: Abscess; Adult; Anti-Bacterial Agents; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Exudate | 2011 |
Comparison of intravenous and oral antibiotic therapy in the treatment of fractures caused by low-velocity gunshots. A prospective, randomized study of infection rates.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporin | 1996 |
[Prospects of clinical uses of quinolones in burn wound infections].
Topics: Animals; Anti-Infective Agents; Burns; Ciprofloxacin; Humans; Norfloxacin; Wound Infection | 1990 |
4 trials available for ciprofloxacin and Infection, Wound
| Article | Year |
|---|---|
Comparison of intravenous and oral antibiotic therapy in the treatment of fractures caused by low-velocity gunshots. A prospective, randomized study of infection rates.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporin | 1996 |
[A trial of the clinical use of Cifran in treating infections in burn wounds and the infectious complications of burns].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Burns; Burns, Inhalation; Ciprofloxacin; Female; Hum | 2000 |
Prospective, randomized, double-blind study comparing single-agent antibiotic therapy, ciprofloxacin, to combination antibiotic therapy in open fracture wounds.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chi-Square Distribution; Ciprofloxacin; D | 2000 |
Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
Topics: Administration, Oral; Bacterial Infections; Cefotaxime; Ciprofloxacin; Double-Blind Method; Female; | 1989 |
60 other studies available for ciprofloxacin and Infection, Wound
| Article | Year |
|---|---|
In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.
Topics: Animals; beta-Lactamases; Burns; Cephalosporins; Drug Resistance, Multiple, Bacterial; Lung Diseases | 2007 |
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug | 2018 |
Nonimmunogenic Hydrogel-Mediated Delivery of Antibiotics Outperforms Clinically Used Formulations in Mitigating Wound Infections.
Topics: Animals; Anti-Bacterial Agents; Cholic Acids; Ciprofloxacin; Dipeptides; Drug Carriers; Drug Liberat | 2021 |
Lactoferricin-inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine wounds.
Topics: Animals; Biofilms; Ciprofloxacin; Mice; Mice, Inbred BALB C; Peptides; Pseudomonas aeruginosa; Pseud | 2022 |
Antibacterial activity of chitosan-based nanohybrid membranes against drug-resistant bacterial isolates from burn wound infections.
Topics: Anti-Bacterial Agents; Bentonite; Burns; Chitosan; Ciprofloxacin; Humans; Methicillin-Resistant Stap | 2022 |
Mesoporous silica-coated silver nanoparticles as ciprofloxacin/siRNA carriers for accelerated infected wound healing.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Metal Nanoparticles; Mice; RNA, Sma | 2022 |
Design of Phage-Cocktail-Containing Hydrogel for the Treatment of
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteriophages; Ciprofloxacin; Disease Models, | 2023 |
Evaluation of combined carbon dots and ciprofloxacin on the expression level of pslA, pelA, and ppyR genes and biofilm production in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from burn wound infection in Iran.
Topics: Anti-Bacterial Agents; Biofilms; Burns; Ciprofloxacin; Humans; Iran; Microbial Sensitivity Tests; Ps | 2023 |
Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
Topics: Anti-Bacterial Agents; Bacterial Infections; Biocatalysis; Biofilms; Ciprofloxacin; Drug Carriers; D | 2019 |
Agricultural Injury-Associated
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Chromobacterium; Ciprofloxacin; Farmers; | 2020 |
Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Risk Factors Among Patients With Wound Infections at Debre Markos Referral Hospital, Northwest, Ethiopia.
Topics: Agar; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Res | 2022 |
Necrotizing wound infection from a tilapia fish injury.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Fasciitis, Necrotizing; Female; Humans; | 2017 |
Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Topics: Anti-Bacterial Agents; Biofilms; Biological Therapy; Cell Line; Ciprofloxacin; Combined Modality The | 2019 |
Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Calgranulin A; Chronic Disease; Ciprofloxacin; Colony Coun | 2020 |
[Infections in diabetic foot. Choice of empirical antibiotic regimen].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellit | 2019 |
Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Burns; Ciprofloxacin; Disease Models, Animal; Drug Syn | 2013 |
Two cases of Kerstersia gyiorum isolated from sites of chronic infection.
Topics: Alcaligenaceae; Anti-Bacterial Agents; Bacteriological Techniques; Chronic Disease; Ciprofloxacin; D | 2013 |
Microbial profile of diabetic foot infections in Trinidad and Tobago.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Diabetic Foot; Drug Resistance, Mult | 2013 |
The antimicrobial screening of a Barbadian medicinal plant with indications for use in the treatment of diabetic wound infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Barbados; Ciprofloxacin; Colony-Forming Units Assay; Di | 2012 |
[Infection of the hand: evaluation of a two-stage therapy].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial I | 2014 |
Efficacy of purified lactonase and ciprofloxacin in preventing systemic spread of Pseudomonas aeruginosa in murine burn wound model.
Topics: Animals; Anti-Bacterial Agents; Burns; Chemokine CXCL2; Ciprofloxacin; Disease Models, Animal; Inter | 2015 |
[Methicillin-resistant Staphylococcus aureus carrying the mecC gene in a patient with a wound infection].
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Debridement; Drug Resistance, Mul | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ce | 2016 |
Ciprofloxacin-loaded keratin hydrogels reduce infection and support healing in a porcine partial-thickness thermal burn.
Topics: Animals; Burns; Ciprofloxacin; Disease Models, Animal; Drug Carriers; Female; Hydrogels; Keratins; M | 2016 |
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; | 2009 |
Septic shock from penetrating leg injury with Vibrio vulnificus infection.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Female; Humans; Injections, Int | 2009 |
An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacteria; Bandages; Biofilms; Ciprofloxacin; Fl | 2010 |
Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment.
Topics: Anti-Bacterial Agents; Bandages; Biofilms; Ciprofloxacin; Microbial Viability; Pseudomonas aeruginos | 2010 |
Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Ba | 2012 |
A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds.
Topics: Adult; Aged; Aged, 80 and over; Amides; Anti-Infective Agents; Bacteriophages; Biocompatible Materia | 2002 |
Improved collagen bilayer dressing for the controlled release of drugs.
Topics: Animals; Anti-Bacterial Agents; Bandages; Cattle; Ciprofloxacin; Collagen; Colony Count, Microbial; | 2004 |
Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Burns; Ciprofloxacin | 2004 |
Bacillus cereus infections in Traumatology-Orthopaedics Department: retrospective investigation and improvement of healthcare practices.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bac | 2005 |
Poly(2-hydroxyethyl methacrylate) wound dressing containing ciprofloxacin and its drug release studies.
Topics: Absorption; Administration, Topical; Anti-Bacterial Agents; Bandages, Hydrocolloid; Biocompatible Ma | 2005 |
Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bites and Stings; Cats; Cefuroxime; Ciprofloxacin; Fe | 2005 |
Black fluid from a traumatic wound.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Merop | 2006 |
[Cervical lymphadenitis due to Mycobacterium avium in an immunocompetent adult].
Topics: Accidents, Traffic; Adolescent; Ciprofloxacin; Clarithromycin; Ethambutol; Humans; Immunocompetence; | 2007 |
[Clinical cases in Medical Mycology. Case No. 28].
Topics: Abdominal Injuries; Agricultural Workers' Diseases; Anti-Bacterial Agents; Argentina; Ciprofloxacin; | 2007 |
Meticillin-resistant Staphylococcus aureus in the community: homeless are also at risk.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Ill-Housed Persons; Methicill | 2008 |
Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Burns; Child; Ciprofloxacin; Citr | 2008 |
Oral ciprofloxacin for treatment of infection following nail puncture wounds of the foot.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Cellulitis; Ciprofloxacin; Female; F | 1995 |
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.
Topics: Animals; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Guinea Pigs; Male; Ofloxacin; | 1994 |
Wound infection due to Aeromonas sobria.
Topics: Adult; Aeromonas; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; Male; Water Microbiolog | 1993 |
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
Topics: Administration, Oral; Ciprofloxacin; Diarrhea; Gram-Negative Bacterial Infections; Humans; Respirato | 1994 |
Oral ciprofloxacin therapy for Bacillus cereus wound infection and bacteremia.
Topics: Administration, Oral; Adult; Bacillus cereus; Bacteremia; Ciprofloxacin; Humans; Male; Wound Infecti | 1993 |
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Cats; Cipr | 1997 |
Antibiotic prophylaxis after swan bite.
Topics: Adult; Animals; Anti-Infective Agents; Birds; Bites and Stings; Ciprofloxacin; Female; Humans; Wound | 1997 |
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infe | 1998 |
Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?
Topics: Adolescent; Age Factors; Anti-Infective Agents; Biopsy; Burns; Child; Child, Preschool; Ciprofloxaci | 1998 |
Aeromonas hydrophila infection secondary to an electrical burn.
Topics: Aeromonas hydrophila; Aged; Anti-Infective Agents; Burns, Electric; Ciprofloxacin; Female; Gentamici | 2000 |
Management of a heavily exuding, painful wound with necrotising subcutaneous infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasciiti | 2002 |
Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics.
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Burns; Carbenicillin; Ceftazidi | 2002 |
[Symposium "Ciflozin (ciprofloxacin)--a broad-spectrum antibacterial drug"].
Topics: Bacterial Infections; Ciprofloxacin; Drug Evaluation; Germany, West; Humans; Moscow; Respiratory Tra | 1992 |
Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
Topics: Animals; Antibodies, Monoclonal; Antigens, Bacterial; Burns; Cellulitis; Ciprofloxacin; Immunotherap | 1991 |
Ciprofloxacin-warfarin interaction.
Topics: Aged; Ciprofloxacin; Drug Interactions; Humans; Male; Prothrombin Time; Warfarin; Wound Infection | 1991 |
Vibrio vulnificus wound infection treated successfully with oral ciprofloxacin.
Topics: Aged; Cellulitis; Ciprofloxacin; Humans; Male; Vibrio Infections; Wound Infection | 1990 |
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary | 1986 |
[Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Topics: Animals; Bacterial Infections; Burns; Ciprofloxacin; Combined Modality Therapy; Female; Immunoglobul | 1987 |
Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
Topics: ADP Ribose Transferases; Animals; Antibodies, Bacterial; Bacterial Toxins; Burns; Ciprofloxacin; Com | 1987 |
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria | 1988 |